+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2026-2032- Product Image
Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2026-2032- Product Image
Sale

Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081398
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sexually Transmitted Infection Diagnostics Kit Market is projected to reach USD 12.21 Billion in 2026. It is expected to continue growing at a CAGR of 6.16%, reaching USD 17.49 Billion by 2032.

STI Diagnostics Kits: Executive Summary

Sexually transmitted infection (STI) diagnostics kits support screening, diagnosis, treatment selection, and surveillance for infections including chlamydia, gonorrhea, syphilis, human immunodeficiency virus, human papillomavirus, trichomoniasis, and hepatitis B and C. Demand is shaped by persistent infection burdens, asymptomatic transmission, antimicrobial resistance, prevention programs, and the need for accessible testing across clinical and community settings. The market includes laboratory-based assays, rapid tests, molecular platforms, self-collection workflows, and connected digital services, with requirements varying by pathogen, specimen type, intended user, and regulatory pathway.

Testing Is Moving Toward Faster, More Accessible Care

STI diagnostics are shifting from centralized, episodic testing toward decentralized and integrated models. Point-of-care platforms, multiplex assays, self-collected specimens, and pharmacy or community-based services can reduce delays between testing and treatment, particularly where laboratory infrastructure is limited. At the same time, confirmatory testing, quality assurance, specimen transport, data protection, and linkage to clinical care remain essential. The expansion of screening among asymptomatic populations is also increasing the importance of affordability, confidentiality, culturally appropriate services, and repeat testing for people with ongoing exposure risk.

Artificial Intelligence Strengthens Triage, Quality, and Surveillance

Artificial intelligence can contribute to STI diagnostics by supporting image interpretation, laboratory quality checks, workflow prioritization, clinical decision support, and surveillance of testing patterns. Its practical value depends on representative training data, transparent validation, interoperability with laboratory information systems, and safeguards against bias. AI is most useful when it complements validated diagnostic assays rather than replacing them. Governance should address patient consent, privacy, cybersecurity, explainability, human oversight, and monitoring for performance differences across populations and care settings.

Regional Insights: Access and Policy Shape Adoption

North America combines advanced molecular testing capacity with persistent access gaps, uneven screening uptake, and concern about antimicrobial-resistant infections. Latin America is emphasizing expanded primary-care access, sexual-health education, and decentralized testing, while affordability and laboratory reach remain important constraints. Europe benefits from established public-health systems, but countries differ in screening policies, reimbursement, privacy rules, and integration of self-testing. The Middle East is characterized by varied regulatory environments, differing levels of stigma, and uneven diagnostic infrastructure. Africa continues to prioritize affordable, resilient testing and integration with HIV, maternal-health, and primary-care programs. Asia-Pacific presents substantial diversity, with technologically advanced systems alongside settings where community delivery, mobile testing, and supply-chain reliability are critical.

Group Insights: Cooperation Supports Cross-Border Control

ASEAN members face diverse health-system capacities and benefit from harmonized procurement, regional laboratory networks, and services adapted to mobile and underserved populations. BRICS economies bring substantial manufacturing, research, and public-health capabilities, while differences in regulation, reimbursement, and access require locally appropriate implementation. The European Union supports cross-border coordination through common public-health priorities, although national testing pathways remain distinct. G7 members generally have strong diagnostic infrastructure but continue to address equity, resistant infections, and underserved communities. GCC countries can leverage centralized health systems and digital infrastructure while strengthening privacy-sensitive screening and migrant-health access. NATO members have opportunities to reinforce interoperability, preparedness, and continuity of diagnostics during emergencies.

Country Insights: National Priorities Remain Distinct

Australia emphasizes sexual-health surveillance, culturally safe services, and access across remote communities. Brazil is integrating STI testing with public health and primary care while addressing regional disparities. Canada continues to focus on prevention, laboratory quality, and equitable access across provinces and territories. China is expanding diagnostic capacity and digital health capabilities within a large and diverse health system. France, Germany, Italy, and Spain are balancing established laboratory networks with earlier diagnosis, privacy, and improved access for vulnerable populations. India is prioritizing scalable, affordable testing integrated with public-health programs. Japan and South Korea have strong technical capabilities and are addressing screening behavior, aging infrastructure in some settings, and public awareness. Mexico is strengthening decentralized access and surveillance. Russia’s priorities include laboratory capacity, treatment linkage, and regional service variation. The United Kingdom continues to emphasize integrated sexual-health services, rapid diagnosis, and antimicrobial-resistance surveillance. The United States is addressing persistent disparities, prevention gaps, and the expansion of convenient testing pathways.

Priorities for Leaders: Build Trusted, Connected Testing Pathways

Industry leaders should design portfolios around clinical use cases rather than technology alone, combining accurate assays with clear specimen workflows, dependable controls, and actionable results. Partnerships with public-health agencies, laboratories, clinicians, pharmacies, and community organizations can improve reach and treatment linkage. Products should support decentralized deployment without compromising quality, cybersecurity, or regulatory compliance. Leaders should also prepare for antimicrobial-resistance surveillance, multiplex testing needs, self-collection adoption, and interoperability with electronic health records. AI initiatives should begin with narrowly defined, validated applications and continuous post-deployment monitoring. Pricing, training, multilingual instructions, and privacy protections should be treated as core adoption requirements, not secondary features.

Methodology: Evidence-Led Market Assessment

This executive summary applies a structured review of STI diagnostic-kit categories, testing workflows, pathogen-specific requirements, care settings, public-health priorities, regulatory considerations, and regional access conditions. Insights are synthesized from established public-health guidance, regulatory principles, peer-reviewed diagnostic evidence, surveillance practices, and documented healthcare-delivery trends. The assessment distinguishes screening from diagnosis, laboratory testing from point-of-care use, and technology capability from real-world implementation. Because country policies, reporting practices, and access conditions differ, findings are presented as directional, evidence-based themes rather than numerical market claims.

Conclusion: Accessibility and Trust Will Define Progress

The STI diagnostics-kit landscape is being shaped by the combined need for earlier detection, convenient access, resilient laboratory systems, and responsible data use. Molecular and multiplex technologies, self-collection, decentralized services, and carefully governed AI can improve the testing pathway when supported by quality assurance and effective linkage to treatment. Success across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific will depend on adapting solutions to national systems and community needs. Leaders that combine diagnostic performance with affordability, privacy, interoperability, and public-health collaboration will be best positioned to strengthen STI control.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sexually Transmitted Infection Diagnostics Kit Market, by Infection Type
7.1. Introduction
7.2. Chlamydia
7.3. Gonorrhea
7.4. HIV
7.5. Syphilis
8. Sexually Transmitted Infection Diagnostics Kit Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.3. Immunoassay
8.3.1. CLIA
8.3.2. ELISA
8.3.3. Rapid Immunoassay
8.4. Molecular
8.4.1. Isothermal Amplification
8.4.1.1. LAMP
8.4.1.2. RPA
8.4.2. PCR
8.4.2.1. Multiplex PCR
8.4.2.2. Real Time PCR
8.5. Rapid Test
8.5.1. Dipstick
8.5.2. Lateral Flow Assay
9. Sexually Transmitted Infection Diagnostics Kit Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Serum
9.2.2. Whole Blood
9.3. Swab
9.3.1. Endocervical Swab
9.3.2. Rectal Swab
9.3.3. Urethral Swab
9.3.4. Vaginal Swab
9.4. Urine
9.4.1. First Catch Urine
9.4.2. Midstream Urine
10. Sexually Transmitted Infection Diagnostics Kit Market, by Distribution Channel
10.1. Introduction
10.2. Direct Tender
10.3. Hospital Pharmacy
10.4. Online Sales
10.5. Retail Pharmacy
11. Sexually Transmitted Infection Diagnostics Kit Market, by Application
11.1. Introduction
11.2. Confirmation
11.3. Monitoring
11.4. Screening
12. Sexually Transmitted Infection Diagnostics Kit Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Diagnostic Laboratories
12.4. Hospitals
12.5. Research Institutes
13. Sexually Transmitted Infection Diagnostics Kit Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Sexually Transmitted Infection Diagnostics Kit Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Sexually Transmitted Infection Diagnostics Kit Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Becton, Dickinson and Company
17.3. bioMérieux SA
17.4. Danaher Corporation
17.5. F. Hoffmann-La Roche Ltd.
17.6. Hologic, Inc.
17.7. QIAGEN N.V.
17.8. Quest Consumer Inc.
17.9. Quidel Corporation
17.10. Sansure Biotech Inc
17.11. Siemens Healthineers AG
17.12. Thermo Fisher Scientific, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sexually Transmitted Infection Diagnostics Kit Market, Years Considered for the Study
FIGURE 2. Global Sexually Transmitted Infection Diagnostics Kit Market, Research Design
FIGURE 3. Global Sexually Transmitted Infection Diagnostics Kit Market, Research Framework
FIGURE 4. Global Sexually Transmitted Infection Diagnostics Kit Market, Data Triangulation
FIGURE 5. Global Sexually Transmitted Infection Diagnostics Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2025 vs 2032 (%)
FIGURE 7. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Sexually Transmitted Infection Diagnostics Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sexually Transmitted Infection Diagnostics Kit Market Segmentation & Coverage
TABLE 2. Global Sexually Transmitted Infection Diagnostics Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 4. Global Chlamydia Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chlamydia Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chlamydia Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Gonorrhea Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Gonorrhea Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Gonorrhea Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global HIV Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global HIV Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global HIV Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Syphilis Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Syphilis Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Syphilis Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 17. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global CLIA Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global CLIA Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global CLIA Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Rapid Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Rapid Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Rapid Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Molecular Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Molecular Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Molecular Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global LAMP Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global LAMP Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global LAMP Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global RPA Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global RPA Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global RPA Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Multiplex PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Multiplex PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Multiplex PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Rapid Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Rapid Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Rapid Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Dipstick Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Dipstick Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Dipstick Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 63. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Endocervical Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Endocervical Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Endocervical Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Rectal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Rectal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Rectal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Urethral Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Urethral Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Urethral Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Vaginal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Vaginal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Vaginal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global First Catch Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global First Catch Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global First Catch Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Midstream Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Midstream Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Midstream Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Global Confirmation Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Confirmation Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Confirmation Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 150. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 152. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 153. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 154. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 155. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 156. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 157. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 158. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 159. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 160. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. North America Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 165. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 167. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 168. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 169. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 170. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 171. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 172. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 173. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 174. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 175. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Latin America Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 180. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 182. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 183. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 184. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 185. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 186. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 187. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 188. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 189. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 190. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Europe Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 195. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 197. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 198. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 199. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 200. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 201. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 202. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 203. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 204. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 205. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. Middle East Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 210. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 212. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 213. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 214. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 215. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 216. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 217. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 218. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 219. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 220. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Africa Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 226. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 228. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 229. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 230. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 231. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 232. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 233. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 234. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 235. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 236. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. ASEAN Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 241. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 243. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 244. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 245. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 246. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 247. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 248. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 249. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 250. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 251. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. GCC Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 256. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 258. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 259. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 260. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 261. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 262. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 263. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 264. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 265. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 266. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. European Union Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 271. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 273. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 274. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 275. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 276. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 277. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 278. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 279. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 280. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 281. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. BRICS Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 285. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 286. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 287. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 288. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 289. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 290. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 291. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 292. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 293. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 294. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 295. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 296. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. G7 Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 300. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 301. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 302. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 303. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 304. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 305. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by PCR, 2017-2032 (USD Million)
TABLE 306. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Rapid Test, 2017-2032 (USD Million)
TABLE 307. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 308. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Blood, 2017-2032 (USD Million)
TABLE 309. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Swab, 2017-2032 (USD Million)
TABLE 310. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Urine, 2017-2032 (USD Million)
TABLE 311. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. NATO Sexually Transmitted Infection Diagnostics Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. Global Sexually Transmitted Infection Diagnostics Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 315. United States Sexually Transmitted Infection Diagnostics Kit Market Size, 2017-2032 (USD Million)
TABLE 316. United States Sexually Transmitted Infection Diagnostics Kit Market Size, by Infection Type, 2017-2032 (USD Million)
TABLE 317. United States Sexually Transmitted Infection Diagnostics Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 318. United States Sexually Transmitted Infection Diagnostics Kit Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 319. United States Sexually Transmitted Infection Diagnostics Kit Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 320. United States Sexually Tr

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Quest Consumer Inc.
  • Quidel Corporation
  • Sansure Biotech Inc
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.

Related Topics

Related Reports

Sexually Transmitted Disease Diagnostics Market - Global Forecast 2026-2032 - Product Image

Sexually Transmitted Disease Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032 - Product Image

Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
At-Home Sexually Transmitted Infection (STI) Testing Market Report 2026 - Product Image

At-Home Sexually Transmitted Infection (STI) Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sexually Transmitted Diseases (STD) Testing Market Report 2026 - Product Image

Sexually Transmitted Diseases (STD) Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market Size, Share, Trends and Forecast by Type, Device Type, End User, and Region, 2026-2034 - Product Image

Sexually Transmitted Disease Diagnostics Market Size, Share, Trends and Forecast by Type, Device Type, End User, and Region, 2026-2034

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.